|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C07K 16/18 | |||
| C07K 16/30 | |||
| A61K 39/395 |
| (11) | Number of the document | 2155239 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08745187.8 |
| Date of filing the European patent application | 2008-04-05 | |
| (97) | Date of publication of the European application | 2010-02-24 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/059511 |
| Date | 2008-04-05 |
| (87) | Number | WO 2008/124654 |
| Date | 2008-10-16 |
| (30) | Number | Date | Country code |
| 784417 | 2007-04-06 | US |
| (72) |
SABBADINI, Roger, A., US
|
| (73) |
Lpath, Inc.,
4025 Sorrento Valley Blvd., San Diego, CA 92121,
US
|
| (54) | METHOD FOR TREATING MULTIPLE SCLEROSIS USING NEUTRALIZING ANTI-S1P ANTIBODIES |
| METHOD FOR TREATING MULTIPLE SCLEROSIS USING NEUTRALIZING ANTI-S1P ANTIBODIES |